While there is limited data on how GLP-1 agonists affect the efficacy of hormonal contraceptives, it is essential for women using these medications to consult healthcare providers regarding potential interactions
Injectable GLP-1 medications currently have a stronger and more established evidence base for weight loss, but oral options are showing meaningful results in clinical trials: In the head-to-head SURMOUNT-5 trial, researchers reported injectable tirzepatide had a mean weight reduction of about 20.2% at 72 weeks, compared with roughly 13.7% for injectable semaglutide
Snacks and savoury categories represent significant opportunities for innovation
The Prohibited List
Understanding Semaglutide and Pregnancy Semaglutide, commonly known as Ozempic or Wegovy, is widely used to help manage type 2 diabetes and support weight loss
About this article Cite this article Rauner, M., Bozec, A